hFg12的表达与隐球菌性脑膜炎的关系
摘要
目的：通过研究隐球菌性脑膜炎(Cryptococcal meningitis, CM)外周血和脑脊液(Cerebrospinal fluid, CSF)中hFgl2(hunman Fibrinogen-like protein2,人Fgl2凝血酶原酶)凝血酶原酶阳性表达的细胞种类及其表达与病情严重程度的关系,了解隐球菌性脑膜炎患者hFgl2凝血酶原酶的表达与临床意义,探讨hFgl2凝血酶原酶的作用机制。
方法：将观察对象分为隐球菌性脑膜炎组(A组)和健康对照组(B组),分别取A组20例和B组20例外周血提取白细胞行hFgl2凝血酶原酶蛋白(简称hFgl2蛋白)行免疫组化制片,其中A组所取外周血分别来自患者住院确诊后第一次检测脑脊液隐球菌数(第一期)、隐球菌数目下降一半(第二期)、隐球菌数目为零或隐球菌培养阴性(第三期)的三个不同时期；并收集A组配对患者脑脊液提取白细胞行hFgl2蛋白免疫组化制片。观察采集到的hFgl2蛋白表达阳性白细胞图像中阳性表达部位及强度,并使用MIAS医学图像分析软件测定反映hFgl2蛋白表达情况的灰度值(hFgl2蛋白表达越高,平均灰度值数值越低。即：hFgl2蛋白表达情况与所测定的灰度值呈负向关系)。以SPSS13.0统计软件分析比较两组中hFgl2蛋白的表达差异和A组在三个不同时期表达的差异,了解hFgl2在A组中的表达与脑脊液隐球菌数、脑脊液生化检查和隐球菌荚膜抗原定量之间的相关关系。
结果：
1.hFgl2蛋白在A、B两组外周血单核细胞和中性粒细胞中均有表达,两组单核细胞中hFg12表达的平均灰度值分别为(114.49±11.82)、(137.56±10.64),经比较,差异有统计学意义(P<0.05)。两组中性粒细胞hFgl2表达的平均灰度值分别为(111.71±8.62)、(143.56±12.57),经比较,差异有统计学意义(P<0.05)。再行组内单核细胞与中性粒细胞hFgl2蛋白表达的平均灰度值比较,差异无统计学意义(P>0.05)。
2.hFgl2蛋白在隐球菌性脑膜炎脑脊液的单核细胞和中性粒细胞中均有表达,阳性组与阴性对照组单核细胞hFgl2表达的平均灰度值为(113.33±8.07)、(147.25±9.72),经比较,差异有统计学意义(P<0.05)；阳性组与阴性对照组中性粒细胞hFgl2表达的平均灰度值分别为(115.44±8.67)(149.25±8.57),经比较,差异有统计学意义(P<0.05)行阳性组内单核细胞与中性粒细胞hFgl2蛋白表达的平均灰度值比较,差异无统计学意义(P>0.05)。
3.hFgl2在A组三个不同时期外周血的单核细胞和中性粒细胞中的表达均为阳性,单核细胞hFgl2表达的平均灰度值分别为(101.87±12.11)、(106.63±8.38)、(118.37±11.26),三组比较,差异有统计学意义(P<0.05)。再行组内两两比较差异均有统计学意义(P<0.05),中性粒细胞hFgl2表达的平均灰度值分别为(103.44±13.51)、(107.31±8.87)、(120.334±9.92),三组比较,差异有统计学意义(P<0.05)。再行组内两两比较差异均有统计学意义(P<0.05)。单核细胞和中性粒细胞hFgl2表达的平均灰度值同期进行比较,差异无统计学意义(P>0.05)。
4.hFgl2在A组三个不同时期脑脊液的单核细胞和中性粒细胞中的表达均为阳性,单核细胞hFgl2表达的平均灰度值分别为(101.314±8.19)、(106.284±7.62)、(120.264±12.62)。三组比较,差异有统计学意义(P<0.05)。再行组内两两比较差异均有统计学意义(P<0.05)。中性粒细胞hFgl2表达的平均灰度值分别为(103.23±9.08)、(110.38±8.75)、(121.06±10.43),三组比较,差异有统计学意义(P<0.05)。再行组内两两比较差异均有统计学意义(P<0.05)。单核细胞和中性粒细胞hFgl2表达的平均灰度值同期进行比较,差异无统计学意义(P>0.05)。
5.A组外周血单核细胞和中性粒细胞hFgl2蛋白表达的平均灰度值与脑脊液隐球菌数均呈负相关(单核细胞r。(隐球菌数)=-0.36,P=0.033,中性粒细胞rs(隐球菌数)=-0.374,P=0.011)(hFg12蛋白的平均灰度值与隐球菌性脑膜炎组的严重程度呈负相关,即隐球菌性脑膜炎组外周血单核细胞和中性粒细胞中hFgl2蛋白表达强度与脑脊液隐球菌数成正相关)。hFgl2蛋白的平均灰度值与脑脊液生化检查和隐球菌荚膜抗原定量的相关性经检验差异无统计学意义(P>0.05)。
6.A组脑脊液单核细胞和中性粒细胞,hFgl2蛋白表达的平均灰度值与脑脊液隐球菌数均呈负相关(单核细胞rs(隐球菌数)=-0.323,P=0.008,中性粒细胞rs(隐球菌数)=-0.354,P=0.007)。hFgl2蛋白的平均灰度值与脑脊液生化检查和隐球菌荚膜抗原定量的相关性经检验差异无统计学意义(P>0.05)。
结论：
1.hFg12蛋白能够表达于隐球菌性脑膜炎患者及健康对照组外周血单核细胞和中性粒细胞中,且表达程度相当。
2.hFgl2蛋白能够表达于隐球菌性脑膜炎脑脊液单核细胞和中性粒细胞中,且表达程度相当。
3.hFg12蛋白在隐球菌性脑膜炎患者外周血中单核细胞和中性粒细胞的表达与在脑脊液单核细胞和中性粒细胞中的表达一致,其表达强度均随着病情的减轻而逐渐下降.
4.隐球菌性脑膜炎患者hFg12蛋白表达的强度与脑脊液隐球菌数成正相关。
Objective:To detect the protein expressions of hfg12 (human fibrinogen like protein 2) from peripheral blood monocytes as well as Cerebrospinal fluid in patients with Cryptococcal meningitis and try to make clear the correlation and possible involvement between these diseases and the expression of hFgl2.Research hFgl2 prothrombin enzyme positive expression of mononuclear cells and Cerebrospinal fluid cryptococcal number、CSF protein and Cryptococcal capsular antigen quantitative to determine the correlation between the degree of The severity of meningitis, and understand the sensitivity of the reflection hFgl2 prothrombin enzyme expression determination of the clinical significance.
Methods:
1.Acquisition with complete clinical data of 20 cases with Cryptococcal meningitis(A) peripheral blood smear as experimental,20 cases of the healthy check-up peripheral blood smear as control group (B).
2. Patients in group B were detected in the hospital diagnosed the first time the number of cerebrospinal fluid cryptococcal, cryptococcal fall by half the number of cryptococcal number of zero or cryptococcal collection of three peripheral blood in three different periods of culture-negative; And collection of matching patients with cryptococcal meningitis lumbar puncture the cerebrospinal fluid extract cells
3.Application immunohistochemistry methods were used in the treatment of Cryptococcal meningitis group and the normal group peripheral blood monocytes.And using the two-step immunohistochemistry methods detected to Fgl2 protein expression in the collected in the Cerebrospinal fluid.
4.The statistical data of expression was analysed by SPSS13.0.
Results:
1.Fgl2 proteins was detected in two groups of peripheral blood monocytes.Its expression of average gray level respectively was(Group A): (114.49±11.82), (Group B):(137.56±10.64), The two groups by statistical analysis, a statistically significant difference(P<0.05), Two sets of neutrophil cell expression hFgl2 average gray value (111.71±8.62), (143.56±12.57), by comparison, the difference was statistically significant (P<0.05).Prompt hFgl2 protein highly expressed in peripheral blood mononuclear cells and neutrophil cell of the cryptococcal meningitis group·
2.hFgl2 protein expression in cryptococcal meningitis in cerebrospinal fluid mononuclear cells.. Average gray value of its expression with the negative control group was (103.33±8.07)、(147.25±9.72), The two groups by statistical analysis, a statistically significant difference(P<0.05), Positive and negative control group, the average gray value of neutrophils hFgl2 expression, respectively (115.44±8.67) (149.25±8.57), by comparison, the difference was statistically significant (P<0.05) single-core line-positive groupcells compared to the average gray value and to neutrophils hFgl2 protein expression was no significant difference (P> 0.05).Prompt hFgl2 protein highly expressed in the cryptococcal meningitis group cerebrospinal fluid mononuclear cells and neutrophil cell.
3.the hFgl2 expression in Peripheral blood mononuclear cells and neutrophil cell.in three different periods of cryptococcal meningitis were positive, which Cerebrospinal fluid cryptococcal number of hospital diagnosed the first time, cryptococcosis decreased by half the number, cryptococcal number is zero or cryptococcal culture negative. Average gray value of its expression with the negative control group was (101.87±12.11) (106.63±8.38)、(118.37±11.26) respectively. There was significant difference in three groups (P<0.05). The average gray value of neutrophils hFgl2 expression, respectively (103.44±13.51) (107.31±8.87), (120.33±9.92), three groups, the difference was statistically significant (P<0.05). Further pairwise comparisons within the group differences were statistically significant (P<0.05). Expression by monocytes and neutrophils hFgl2 average gray value over the same period were compared, no statistically significant difference (P> 0.05).
4. the hFgl2 expression in Cerebrospinal fluid mononuclear cells in three different periods of cryptococcal meningitis were positive, which Cerebrospinal fluid cryptococcal number of hospital diagnosed the first time, cryptococcosis decreased by half the number, cryptococcal number is zero or cryptococcal culture negative. Average gray value of its expression with the negative control group was (101.31±8.19)、(106.28±7.62)、(120.26±12.62) respectively. There was significant difference in three groups (P<0.05). The average gray value of neutrophils hFgl2 expression, respectively (103.23±9.08), (110.38±8.75), (121.06±10.43), three groups, the difference was statistically significant (P <0.05). Further pairwise comparisons within the group differences were statistically significant (P<0.05). Expression by monocytes and neutrophils hFgl2 average gray value over the same period were compared, no statistically significant difference (P> 0.05).Prompt the expression of hFgl2 in cryptococcal meningitis Cerebrospinal fluid's positive values and disease severity of a positive correlation.
5. In Peripheral blood mononuclear cells and neutrophil cell, the average gray value of hFg12 protein in Cryptococcal meningitis group and cerebrospinal fluid cryptococcal number was negatively correlated (P<0.05),it means the average gray value of hFgl2 protein with the cryptococcal meningitis group, the severity was negatively correlated, Cryptococcal meningitis in peripheral blood mononuclear cells of hFgl2 protein expression intensity of cerebrospinal fluid cryptococcal number into a positive correlation. There was no significant difference in the correlation of the average gray value of hFgl2 protein and CSF protein and cryptococcal capsular antigen quantitative(P>0.05).
6. In cerebrospinal fluid mononuclear cells and neutrophil cell, the average gray value of hFgl2 protein in Cryptococcal meningitis group and cerebrospinal fluid cryptococcal number was negatively correlated (P<0.05), it means the average gray value of hFgl2 protein with the cryptococcal meningitis group, the severity was negatively correlated, Cryptococcal meningitis in Cerebrospinal fluid mononuclear cells of hFgl2 protein expression intensity of cerebrospinal fluid cryptococcal number into a positive correlation. There was no significant difference in the correlation of the average gray value of hFgl2 protein and CSF protein and cryptococcal capsular antigen quantitative(P>0.05).
Conclusions:
1. Fg12 protein can be in the human peripheral blood monocytes.
2. hFgl2 protein can be expressed in cryptococcal meningitis in cerebrospinal fluid mononuclear cells·
3 the espression of hFgl2 protein reduced with the cryptococcal meningitis severity of the disease mitigate,and the espression of hFgl2 protein in peripheral blood and cerebrospinal fluid mononuclear cells showing the synchronization. prothrombinase hFgl2 is expected to become another evaluation of the degree of damage in the nervous system of patients with cryptococcal meningitis·
方法：将观察对象分为隐球菌性脑膜炎组(A组)和健康对照组(B组),分别取A组20例和B组20例外周血提取白细胞行hFgl2凝血酶原酶蛋白(简称hFgl2蛋白)行免疫组化制片,其中A组所取外周血分别来自患者住院确诊后第一次检测脑脊液隐球菌数(第一期)、隐球菌数目下降一半(第二期)、隐球菌数目为零或隐球菌培养阴性(第三期)的三个不同时期；并收集A组配对患者脑脊液提取白细胞行hFgl2蛋白免疫组化制片。观察采集到的hFgl2蛋白表达阳性白细胞图像中阳性表达部位及强度,并使用MIAS医学图像分析软件测定反映hFgl2蛋白表达情况的灰度值(hFgl2蛋白表达越高,平均灰度值数值越低。即：hFgl2蛋白表达情况与所测定的灰度值呈负向关系)。以SPSS13.0统计软件分析比较两组中hFgl2蛋白的表达差异和A组在三个不同时期表达的差异,了解hFgl2在A组中的表达与脑脊液隐球菌数、脑脊液生化检查和隐球菌荚膜抗原定量之间的相关关系。
结果：
1.hFgl2蛋白在A、B两组外周血单核细胞和中性粒细胞中均有表达,两组单核细胞中hFg12表达的平均灰度值分别为(114.49±11.82)、(137.56±10.64),经比较,差异有统计学意义(P<0.05)。两组中性粒细胞hFgl2表达的平均灰度值分别为(111.71±8.62)、(143.56±12.57),经比较,差异有统计学意义(P<0.05)。再行组内单核细胞与中性粒细胞hFgl2蛋白表达的平均灰度值比较,差异无统计学意义(P>0.05)。
2.hFgl2蛋白在隐球菌性脑膜炎脑脊液的单核细胞和中性粒细胞中均有表达,阳性组与阴性对照组单核细胞hFgl2表达的平均灰度值为(113.33±8.07)、(147.25±9.72),经比较,差异有统计学意义(P<0.05)；阳性组与阴性对照组中性粒细胞hFgl2表达的平均灰度值分别为(115.44±8.67)(149.25±8.57),经比较,差异有统计学意义(P<0.05)行阳性组内单核细胞与中性粒细胞hFgl2蛋白表达的平均灰度值比较,差异无统计学意义(P>0.05)。
3.hFgl2在A组三个不同时期外周血的单核细胞和中性粒细胞中的表达均为阳性,单核细胞hFgl2表达的平均灰度值分别为(101.87±12.11)、(106.63±8.38)、(118.37±11.26),三组比较,差异有统计学意义(P<0.05)。再行组内两两比较差异均有统计学意义(P<0.05),中性粒细胞hFgl2表达的平均灰度值分别为(103.44±13.51)、(107.31±8.87)、(120.334±9.92),三组比较,差异有统计学意义(P<0.05)。再行组内两两比较差异均有统计学意义(P<0.05)。单核细胞和中性粒细胞hFgl2表达的平均灰度值同期进行比较,差异无统计学意义(P>0.05)。
4.hFgl2在A组三个不同时期脑脊液的单核细胞和中性粒细胞中的表达均为阳性,单核细胞hFgl2表达的平均灰度值分别为(101.314±8.19)、(106.284±7.62)、(120.264±12.62)。三组比较,差异有统计学意义(P<0.05)。再行组内两两比较差异均有统计学意义(P<0.05)。中性粒细胞hFgl2表达的平均灰度值分别为(103.23±9.08)、(110.38±8.75)、(121.06±10.43),三组比较,差异有统计学意义(P<0.05)。再行组内两两比较差异均有统计学意义(P<0.05)。单核细胞和中性粒细胞hFgl2表达的平均灰度值同期进行比较,差异无统计学意义(P>0.05)。
5.A组外周血单核细胞和中性粒细胞hFgl2蛋白表达的平均灰度值与脑脊液隐球菌数均呈负相关(单核细胞r。(隐球菌数)=-0.36,P=0.033,中性粒细胞rs(隐球菌数)=-0.374,P=0.011)(hFg12蛋白的平均灰度值与隐球菌性脑膜炎组的严重程度呈负相关,即隐球菌性脑膜炎组外周血单核细胞和中性粒细胞中hFgl2蛋白表达强度与脑脊液隐球菌数成正相关)。hFgl2蛋白的平均灰度值与脑脊液生化检查和隐球菌荚膜抗原定量的相关性经检验差异无统计学意义(P>0.05)。
6.A组脑脊液单核细胞和中性粒细胞,hFgl2蛋白表达的平均灰度值与脑脊液隐球菌数均呈负相关(单核细胞rs(隐球菌数)=-0.323,P=0.008,中性粒细胞rs(隐球菌数)=-0.354,P=0.007)。hFgl2蛋白的平均灰度值与脑脊液生化检查和隐球菌荚膜抗原定量的相关性经检验差异无统计学意义(P>0.05)。
结论：
1.hFg12蛋白能够表达于隐球菌性脑膜炎患者及健康对照组外周血单核细胞和中性粒细胞中,且表达程度相当。
2.hFgl2蛋白能够表达于隐球菌性脑膜炎脑脊液单核细胞和中性粒细胞中,且表达程度相当。
3.hFg12蛋白在隐球菌性脑膜炎患者外周血中单核细胞和中性粒细胞的表达与在脑脊液单核细胞和中性粒细胞中的表达一致,其表达强度均随着病情的减轻而逐渐下降.
4.隐球菌性脑膜炎患者hFg12蛋白表达的强度与脑脊液隐球菌数成正相关。
Objective:To detect the protein expressions of hfg12 (human fibrinogen like protein 2) from peripheral blood monocytes as well as Cerebrospinal fluid in patients with Cryptococcal meningitis and try to make clear the correlation and possible involvement between these diseases and the expression of hFgl2.Research hFgl2 prothrombin enzyme positive expression of mononuclear cells and Cerebrospinal fluid cryptococcal number、CSF protein and Cryptococcal capsular antigen quantitative to determine the correlation between the degree of The severity of meningitis, and understand the sensitivity of the reflection hFgl2 prothrombin enzyme expression determination of the clinical significance.
Methods:
1.Acquisition with complete clinical data of 20 cases with Cryptococcal meningitis(A) peripheral blood smear as experimental,20 cases of the healthy check-up peripheral blood smear as control group (B).
2. Patients in group B were detected in the hospital diagnosed the first time the number of cerebrospinal fluid cryptococcal, cryptococcal fall by half the number of cryptococcal number of zero or cryptococcal collection of three peripheral blood in three different periods of culture-negative; And collection of matching patients with cryptococcal meningitis lumbar puncture the cerebrospinal fluid extract cells
3.Application immunohistochemistry methods were used in the treatment of Cryptococcal meningitis group and the normal group peripheral blood monocytes.And using the two-step immunohistochemistry methods detected to Fgl2 protein expression in the collected in the Cerebrospinal fluid.
4.The statistical data of expression was analysed by SPSS13.0.
Results:
1.Fgl2 proteins was detected in two groups of peripheral blood monocytes.Its expression of average gray level respectively was(Group A): (114.49±11.82), (Group B):(137.56±10.64), The two groups by statistical analysis, a statistically significant difference(P<0.05), Two sets of neutrophil cell expression hFgl2 average gray value (111.71±8.62), (143.56±12.57), by comparison, the difference was statistically significant (P<0.05).Prompt hFgl2 protein highly expressed in peripheral blood mononuclear cells and neutrophil cell of the cryptococcal meningitis group·
2.hFgl2 protein expression in cryptococcal meningitis in cerebrospinal fluid mononuclear cells.. Average gray value of its expression with the negative control group was (103.33±8.07)、(147.25±9.72), The two groups by statistical analysis, a statistically significant difference(P<0.05), Positive and negative control group, the average gray value of neutrophils hFgl2 expression, respectively (115.44±8.67) (149.25±8.57), by comparison, the difference was statistically significant (P<0.05) single-core line-positive groupcells compared to the average gray value and to neutrophils hFgl2 protein expression was no significant difference (P> 0.05).Prompt hFgl2 protein highly expressed in the cryptococcal meningitis group cerebrospinal fluid mononuclear cells and neutrophil cell.
3.the hFgl2 expression in Peripheral blood mononuclear cells and neutrophil cell.in three different periods of cryptococcal meningitis were positive, which Cerebrospinal fluid cryptococcal number of hospital diagnosed the first time, cryptococcosis decreased by half the number, cryptococcal number is zero or cryptococcal culture negative. Average gray value of its expression with the negative control group was (101.87±12.11) (106.63±8.38)、(118.37±11.26) respectively. There was significant difference in three groups (P<0.05). The average gray value of neutrophils hFgl2 expression, respectively (103.44±13.51) (107.31±8.87), (120.33±9.92), three groups, the difference was statistically significant (P<0.05). Further pairwise comparisons within the group differences were statistically significant (P<0.05). Expression by monocytes and neutrophils hFgl2 average gray value over the same period were compared, no statistically significant difference (P> 0.05).
4. the hFgl2 expression in Cerebrospinal fluid mononuclear cells in three different periods of cryptococcal meningitis were positive, which Cerebrospinal fluid cryptococcal number of hospital diagnosed the first time, cryptococcosis decreased by half the number, cryptococcal number is zero or cryptococcal culture negative. Average gray value of its expression with the negative control group was (101.31±8.19)、(106.28±7.62)、(120.26±12.62) respectively. There was significant difference in three groups (P<0.05). The average gray value of neutrophils hFgl2 expression, respectively (103.23±9.08), (110.38±8.75), (121.06±10.43), three groups, the difference was statistically significant (P <0.05). Further pairwise comparisons within the group differences were statistically significant (P<0.05). Expression by monocytes and neutrophils hFgl2 average gray value over the same period were compared, no statistically significant difference (P> 0.05).Prompt the expression of hFgl2 in cryptococcal meningitis Cerebrospinal fluid's positive values and disease severity of a positive correlation.
5. In Peripheral blood mononuclear cells and neutrophil cell, the average gray value of hFg12 protein in Cryptococcal meningitis group and cerebrospinal fluid cryptococcal number was negatively correlated (P<0.05),it means the average gray value of hFgl2 protein with the cryptococcal meningitis group, the severity was negatively correlated, Cryptococcal meningitis in peripheral blood mononuclear cells of hFgl2 protein expression intensity of cerebrospinal fluid cryptococcal number into a positive correlation. There was no significant difference in the correlation of the average gray value of hFgl2 protein and CSF protein and cryptococcal capsular antigen quantitative(P>0.05).
6. In cerebrospinal fluid mononuclear cells and neutrophil cell, the average gray value of hFgl2 protein in Cryptococcal meningitis group and cerebrospinal fluid cryptococcal number was negatively correlated (P<0.05), it means the average gray value of hFgl2 protein with the cryptococcal meningitis group, the severity was negatively correlated, Cryptococcal meningitis in Cerebrospinal fluid mononuclear cells of hFgl2 protein expression intensity of cerebrospinal fluid cryptococcal number into a positive correlation. There was no significant difference in the correlation of the average gray value of hFgl2 protein and CSF protein and cryptococcal capsular antigen quantitative(P>0.05).
Conclusions:
1. Fg12 protein can be in the human peripheral blood monocytes.
2. hFgl2 protein can be expressed in cryptococcal meningitis in cerebrospinal fluid mononuclear cells·
3 the espression of hFgl2 protein reduced with the cryptococcal meningitis severity of the disease mitigate,and the espression of hFgl2 protein in peripheral blood and cerebrospinal fluid mononuclear cells showing the synchronization. prothrombinase hFgl2 is expected to become another evaluation of the degree of damage in the nervous system of patients with cryptococcal meningitis·
引文
1. Levy G A, Liu M, Ding J, et al. Molecular and functional analysis of the human prothrombinase gene (HFG L2) and its role in viral hepatitis [J].Am J Pathol,2000,156 (4):1217-1225.
2.陈永乐,周利平,陈红英,等.纤维介素在硬皮病血管病变中的表达[J].华中医学杂志,2006,30(5)：406-407.
3.汪艳,王朝晖,李晓卫,等.Fg12凝血酶原酶介导的微血栓形成在2型糖尿病大鼠肾脏损害中的作用[J].微循环学杂志,2008,18(3)：12-15.
4. Liu, H Zhang, L Cybulsky, et al. Identification of the receptor for Fgl2 and implication for susceptibility to mouse hepatitis virus (MHV-3)-induced fulminant hepatitis[J]. Advances in Experimental Medicine and Biology,2006,581; 421-425.
5. 刘艳玲,曾其莉,王静丽,等.纤维介素蛋白2凝血酶原酶在人肝癌细胞增殖和凋亡中的作用[J].中西医结合肝病杂志,2010,20(3)：149-152.
6. 周利平,严伟明,陈红英,等.人纤维介素在系统性红斑狼疮和结节性血管炎患者皮损中的检测及意义[J].中国皮肤性病学杂志,2007,21(4)：210-212.
7. 朱帆,宁琴,陈悦,等.重型乙型肝炎患者肝组织中人纤维介素基因的检测及其与临床转归关系的探讨[J]. 中华肝脏病杂志,2004,12(7)：385-388.
8. Simon CR, David KCC, Anthony JF. Disordered regulation of coagulation and platelet activation in xenotransplantation [J]. Xenotransplantation, 2000,7(3):166-175.
9. 严小枫,宁琴,严伟明,等.人纤维介素在系统性红斑狼疮患者外周血单个核细胞中的表达及意义[J].中华血液学杂志2005,26(3)：186-187.
10 原彤彤,玉艳红.hFgl2凝血酶原酶蛋白的表达与慢性重型肝炎、慢性乙型肝炎及肝癌的关系.[硕士学位论文],广西医科大学,2011.
11 Brouwer Annemarie E, Hoogendoorn Elizabeth H, Vander Meer Jos W M. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia:defective cytokine production and reversal by recombinant interferon-gamma therapy [J]. Clin Infect Dis,2004,39(9):83-87.
12 Neumann H, Schmidt H, Cavalie A, et al. Major histocompatibility complex (MHC) class Ⅰ gene expression in single neurons of the central nervous system:differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha[J].J Exp Med,1997,185(2):305-316.
13 Gabrilovich DI, NagaraJ S.Myeloid-derived suppressor cells as regulators of the immune system [J].NatRev Immuno,2009,9(3):162-174.
14 易芳,谭利民,肖波.隐球菌性脑膜炎78例脑脊液细胞学改变[J].脑与神经疾病杂志,2010,18(2)：135-136.
15 Paul S, Tabassum S, Islam MN.Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection[J].200 4,30(2):71-77.
16 Ning Q, Sun Y, Han M, et al. Role of fibrinogen-like protein 2 prothrombinase fibroleukin in experimental and human allograft rejection[J]. J Immunol,2005,174(11):7403-7411.
17 Marazzi S,Blum S,Hartmann R,et al.Characterization of human fibroleukin,a fibrinogen-like protein secreted by T lymphocytes[J].J Immunol.1998,161(1):138-147.
18 余秋实,王朝晖.Fgl2和TNF-α在急性心肌梗死患者和缺血再灌注大鼠外周血中表达和意义.[硕士学位论文],华中科技大学,2010.
19 李学军,夏凌辉,魏文宁,等.重型肝炎患者Fg12凝血酶原酶基因的表达[J].华中科技大学学报(医学版),2003,32(6)：613-615.
20 林航,倪铭孔,杨渤生,等.脑脊液肿瘤坏死因子及白细胞介素6的检测对感染性脑膜炎鉴别诊断的临床意义[J].临床神经病学杂志,1999,12(3)：169-170.
21 周林甫,康涛,孙东,等.隐球菌性脑膜炎及病毒性脑炎患者脑脊液IL-6、IL-10和TNF-α含量检测及其临床意义[J].神经损伤与功能重建,2011,6(2)：114-117.
22 Yuwaraj S, Ding JW, Liu MF, et al.Genomic charact erization, localization, and functional expression of FGL2,the human gene encoding fibroleukin:a novel human procoagulant[J]. Genomics, 2001,71(3):330-338.
23 蒋齐勇,王朝晖,刘青松,等.心脏缺血再灌注大鼠Th1/Th2细胞平衡与心脏微血管fg12表达的相关性[J].山东医药,2009,49(25)：20-22.
24 Knackstedt MK, Zenclussen AC, Hertwig K, et al. Th1 cyt okines and the prothrombinase fg12 in stress-triggered and inflammatory abort ion[J]. Am J Reprod Immunol,2003,49(4):210-220.
25 周华东,李敬诚,张映琦,脑缺血再灌注TNF-α和抗Mac-1抗体对粒细胞粘附作用的实验研究[J].重庆医学,2003,32(5)：548-549.
26 naldini A,Thrombim enhances T cell proliferative responses and cytokine production[J].Cell Immunol,1993,147:367-377
27 曹艳云,徐顺明,汪晓军,等.荚膜在新生隐球菌致人脐静脉内皮细胞损伤中的作用[J].第二军医大学报,2007,28(2)：148-150.
1. Liu, H Zhang, L Cybulsky, et al. Identification of the receptor for Fgl2 and implication for susceptibility to mouse hepatitis virus (MHV-3)-induced fulminant hepatitis[J].Advances in Experimental Medicine and Biology,2006,581; 421-425.
2. 刘艳玲,曾其莉,王静丽,等.纤维介素蛋白2凝血酶原酶在人肝癌细胞增殖和凋亡中的作用[J].中西医结合肝病杂志,2010,20(3)：149-152.
3. 周利平,严伟明,陈红英,等.人纤维介素在系统性红斑狼疮和结节性血管炎患者皮损中的检测及意义[J].中国皮肤性病学杂志,2007,21(4)：210-212.
4. Marazzi S,Blum S,Hartmann R,et al.Characterization of human fibroleukin,a fibrinogen-like protein secreted by T lymphocytes[J].J Immunol.1998,161(1):138-147.
5. Ghanekar A,Mendicino M,Liu H,et al.Endothelial induction of fg12 contributes to thrombosis during acute vascular xenograft rejection[J].J Immunol.2004,172(9):5693-701
6. Gary A. Levy, mingfeng Liu, et al.Molecular and Functional Analysis of the Human Prothrombinase Gene (hFgl2) and Its Role in Viral Hepatitis[J].American Journal of Pathology.2000,156:1217-1225.
7. 陈永乐,周利平,陈红英,等.纤维介素在硬皮病血管病变中的表达[J].华中医学杂志,2006,30(5)：406-407.
8. 汪艳,王朝晖,李晓卫,等.Fg12凝血酶原酶介导的微血栓形成在2型糖尿病大鼠肾脏损害中的作用[J].微循环学杂志,2008,18(3)：12-15.
9. Ding Y, Liu K, Wang Y.Expression and significance of fgl2 prothrombinase in cardiac microvascular endothelial cells of rats with type 2 diabetes[J]. J Huazhong Univ Sci Technolog Med Sci. 2010,30(5):575-81.
10 Paul S, Tabassum S, Islam MN.Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection[J].200 4,30(2):71-77.
11. Ning Q, Sun Y, Han M, et al. Role of fibrinogen-like protein 2 prothrombinase fibroleukin in experimental and human allograft rejection[J]. J Immunol,2005,174(11):7403-7411.
12 严小枫,宁琴,严伟明,等.人纤维介素在系统性红斑狼疮患者外周血单个核细胞中的表达及意义[J].中华血液学杂志,2005,26(3)186-187.
13 余秋实,王朝晖.Fg12和TNF-α在急性心肌梗死患者和缺血再灌注大鼠外周血中表达和意义. [硕士学位论文],华中科技大学,2010.
14. Zhu F, Ning Q, Chen Y.Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity[J].Zhonghua Gan Zang Bing Za Zhi.2004,12(7):385-8.
15. 李学军,夏凌辉,魏文宁,等.重型肝炎患者Fgl2凝血酶原酶基因的表达[J].华中科技大学学报(医学版),2003,32(6)：613-615.
16. 陈悦,宁琴,王宝菊,等.重型乙型肝炎患者肝组织中人纤维介素基因的表达及意义[J].中华医学杂志,2003,83(6)：446-450.
17. 朱帆,宁琴,陈悦,等.重型乙型肝炎患者肝组织中人纤维介素基因的检测及其与临床转归关系的探讨[J].中华肝脏病杂志,2004,12(7)：385-388。
18 Clark DA, Chaouat G, Arck PC, et al. Cytokine-dependent abortion in CBA x DBA/2mice is mediated by the procoagulant fgl2 prothrombinase[J]. J Immunol,1998,160(2):545-549.
19 Simon CR, David KCC, Anthony JF. Disordered regulation of coagulation and platelet act ivation in xenotransplantation [J]. Xenotransplantation, 2000,7(3):166-175.
20 Liu Y, Xu S, Xiao F, Xiong Y,et al.The Fgl2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway[J].Biochem Biophys Res Commun.2010,9(8):369-374.
21 Gabrilovich DI, NagaraJ S.Myeloid-derived suppressor cells as regulators of the immune system [J].NatRev Immuno,2009,9(3):162-174.
22 王成,吴丹霄,刘建华,等.爆发性肝炎小鼠中髓系衍生抑制性细胞对NK细胞活性影响的研究[J].浙江大学学报,2010,39(4)：357-363.
23 蒋齐勇,王朝晖,刘青松,等.心脏缺血再灌注大鼠Th1/Th2细胞平衡与心脏微血管fg12表达的相关性[J].山东医药,2009,49(25)：20-22.
24 Yuwaraj S, Ding JW, Liu MF, et al.Genomic characterization, localization, and functional expression of FGL2,the human gene encoding fibroleukin: a novel human procoagulant[J]. Genomics,2001,71(3):330-338.
25 张天托, 周宇麒, 周风丽,等.TNF-a对小鼠腹腔渗出细胞抗真菌活性的影响[J].中国免疫学杂志,2003,19(5)：336-338.
26 Silva J S, Vespa G N, Cardoso M A, et al. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in miceby inducing nit ricoxide production in infected gama interferon-activated macrophages [J].Infect Immun,1995; 63(12):4862-4872.
27 Hunter C A, Subauste C S, Van Cleave V H et al. Production of gamma interferon by natura killer cells from Toxoplasma gondi-i infected SCID mice:regulation by interleukin-10, interleukin-12, and tumor necrosis factor plpha[J]. Infect Immun,1994; 62(7):2818-2832.
28 Liu Y, Xu S, Xiao F, et al.The Fgl2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway[J].Biochem Biophys Res Commun.2010,9(8):369-374.
29 Fukuda R, Ish imura N, Nguygen TX, et al. The expression of IL-2, IL-4 and interfer on-ganma (IFN-y) mRNA using liver biopsies at different plase of acute exacerbation of chronic hepatitis B[J]. Clin Exp Immunol, 1995,100(3):451-466.
30 Guanhua Su a,Kun Liu a,Yan Wang a, Fibrinogen-like protein 2 expression correlates with microthrombosis in rats with type 2 diabetic nephropathy Journal of Biomedical Research,2011,25(2):120-127
31 汪艳,王朝晖,苏冠华,等.FGL2凝血酶原酶在糖尿病大鼠心脏的表达及意义[J].中国糖尿病杂志.2009,17(8)：629-632.
32 Selzner N, Liu H, Boehnert MU. FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice. J Hepatol.2012,56(1):153-9.
33 Knackstedt MK, Zenclussen AC, Hertwig K, et al. Th1 cyt okines and the prothrombinase fgl2 in stress-triggered and inf lammatory abort ion. Am J Reprod Immunol,2003,49(4):210-220.
34 Su K, Chen F, Yan WM. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma[J]. World J Gastroenterol.2008,14(39):5980-9.
35 周林甫,康涛,孙东,等.隐球菌性脑膜炎及病毒性脑炎患者脑脊液IL-6、IL-10和TNF-α含量检测及其临床意义[J].神经损伤与功能重建,2011,6(2)：114-117.
36 陈利玉,蒋洪敏,韦超凡,等.结核性与新型隐球菌性脑膜炎脑脊液中NO, TNF-α及IL-8水平[J].湖南医科大学报,1997,22(6)：514-516
37 徐赤宇,温海,陈江汉.新生隐球菌感染与细胞因子的相互关系[J].国外医学(微生物学分册),2005,28(4)：30-32.
38 Kubes P, Suzuki M, Granger DN. Nitricoxide:an endogenous modulator of leukocyte adhesion[J]. Proc Natl Acd Sci USA,1991, 88(11):4651-4655
39 马德选,徐如祥.颅脑损伤时脑血管内皮细胞的表达与微循环障碍[J].中国微循环,2001,5(3)：244-246.
40 Yilmaz-Demirdag Y,Wilson B,Lowery-Nordberg M,Bocchini JA Jr,Bahna SL Interleukin-2 treatment for persistent cryptococcal meningitis in a child with idiopathic CD4(+)T lymphocytopenia [J].Allergy Asthma Proc.2008,29(4):421-425.
41 Zhang tiantuo, Kazuyoshi Kawakami, Mahboob H Qureshi,et al. Combined therapy of interleukin-12 and interleukin-18 against Cryptococcus neoformans infection in a murine model [J]. Chinese Medical Journal,2003,116(5):669-672.
42 Mucci A,L Varesio,R Neglia,et al.Antifungal activity of macrophages engineered to produce IFNgamma:inducibility by picolinic acid [J].Med Microbiol Immunol(Berlin) 2003,192:71-78.
43 Donatella Pietrella, Cristina Corbucc, Stefano Perito, et al.Mannoproteins from Cryptococcus neoformans Promote Dendritic Cell Maturation and Activation.Infection and Immunity,2005,15(3):820-827
44 原彤彤,玉艳红.hFgl2凝血酶原酶蛋白的表达与慢性重型肝炎、慢性乙型肝炎及肝癌的关系.[硕士学位论文],广西医科大学,2011
2.陈永乐,周利平,陈红英,等.纤维介素在硬皮病血管病变中的表达[J].华中医学杂志,2006,30(5)：406-407.
3.汪艳,王朝晖,李晓卫,等.Fg12凝血酶原酶介导的微血栓形成在2型糖尿病大鼠肾脏损害中的作用[J].微循环学杂志,2008,18(3)：12-15.
4. Liu, H Zhang, L Cybulsky, et al. Identification of the receptor for Fgl2 and implication for susceptibility to mouse hepatitis virus (MHV-3)-induced fulminant hepatitis[J]. Advances in Experimental Medicine and Biology,2006,581; 421-425.
5. 刘艳玲,曾其莉,王静丽,等.纤维介素蛋白2凝血酶原酶在人肝癌细胞增殖和凋亡中的作用[J].中西医结合肝病杂志,2010,20(3)：149-152.
6. 周利平,严伟明,陈红英,等.人纤维介素在系统性红斑狼疮和结节性血管炎患者皮损中的检测及意义[J].中国皮肤性病学杂志,2007,21(4)：210-212.
7. 朱帆,宁琴,陈悦,等.重型乙型肝炎患者肝组织中人纤维介素基因的检测及其与临床转归关系的探讨[J]. 中华肝脏病杂志,2004,12(7)：385-388.
8. Simon CR, David KCC, Anthony JF. Disordered regulation of coagulation and platelet activation in xenotransplantation [J]. Xenotransplantation, 2000,7(3):166-175.
9. 严小枫,宁琴,严伟明,等.人纤维介素在系统性红斑狼疮患者外周血单个核细胞中的表达及意义[J].中华血液学杂志2005,26(3)：186-187.
10 原彤彤,玉艳红.hFgl2凝血酶原酶蛋白的表达与慢性重型肝炎、慢性乙型肝炎及肝癌的关系.[硕士学位论文],广西医科大学,2011.
11 Brouwer Annemarie E, Hoogendoorn Elizabeth H, Vander Meer Jos W M. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia:defective cytokine production and reversal by recombinant interferon-gamma therapy [J]. Clin Infect Dis,2004,39(9):83-87.
12 Neumann H, Schmidt H, Cavalie A, et al. Major histocompatibility complex (MHC) class Ⅰ gene expression in single neurons of the central nervous system:differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha[J].J Exp Med,1997,185(2):305-316.
13 Gabrilovich DI, NagaraJ S.Myeloid-derived suppressor cells as regulators of the immune system [J].NatRev Immuno,2009,9(3):162-174.
14 易芳,谭利民,肖波.隐球菌性脑膜炎78例脑脊液细胞学改变[J].脑与神经疾病杂志,2010,18(2)：135-136.
15 Paul S, Tabassum S, Islam MN.Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection[J].200 4,30(2):71-77.
16 Ning Q, Sun Y, Han M, et al. Role of fibrinogen-like protein 2 prothrombinase fibroleukin in experimental and human allograft rejection[J]. J Immunol,2005,174(11):7403-7411.
17 Marazzi S,Blum S,Hartmann R,et al.Characterization of human fibroleukin,a fibrinogen-like protein secreted by T lymphocytes[J].J Immunol.1998,161(1):138-147.
18 余秋实,王朝晖.Fgl2和TNF-α在急性心肌梗死患者和缺血再灌注大鼠外周血中表达和意义.[硕士学位论文],华中科技大学,2010.
19 李学军,夏凌辉,魏文宁,等.重型肝炎患者Fg12凝血酶原酶基因的表达[J].华中科技大学学报(医学版),2003,32(6)：613-615.
20 林航,倪铭孔,杨渤生,等.脑脊液肿瘤坏死因子及白细胞介素6的检测对感染性脑膜炎鉴别诊断的临床意义[J].临床神经病学杂志,1999,12(3)：169-170.
21 周林甫,康涛,孙东,等.隐球菌性脑膜炎及病毒性脑炎患者脑脊液IL-6、IL-10和TNF-α含量检测及其临床意义[J].神经损伤与功能重建,2011,6(2)：114-117.
22 Yuwaraj S, Ding JW, Liu MF, et al.Genomic charact erization, localization, and functional expression of FGL2,the human gene encoding fibroleukin:a novel human procoagulant[J]. Genomics, 2001,71(3):330-338.
23 蒋齐勇,王朝晖,刘青松,等.心脏缺血再灌注大鼠Th1/Th2细胞平衡与心脏微血管fg12表达的相关性[J].山东医药,2009,49(25)：20-22.
24 Knackstedt MK, Zenclussen AC, Hertwig K, et al. Th1 cyt okines and the prothrombinase fg12 in stress-triggered and inflammatory abort ion[J]. Am J Reprod Immunol,2003,49(4):210-220.
25 周华东,李敬诚,张映琦,脑缺血再灌注TNF-α和抗Mac-1抗体对粒细胞粘附作用的实验研究[J].重庆医学,2003,32(5)：548-549.
26 naldini A,Thrombim enhances T cell proliferative responses and cytokine production[J].Cell Immunol,1993,147:367-377
27 曹艳云,徐顺明,汪晓军,等.荚膜在新生隐球菌致人脐静脉内皮细胞损伤中的作用[J].第二军医大学报,2007,28(2)：148-150.
1. Liu, H Zhang, L Cybulsky, et al. Identification of the receptor for Fgl2 and implication for susceptibility to mouse hepatitis virus (MHV-3)-induced fulminant hepatitis[J].Advances in Experimental Medicine and Biology,2006,581; 421-425.
2. 刘艳玲,曾其莉,王静丽,等.纤维介素蛋白2凝血酶原酶在人肝癌细胞增殖和凋亡中的作用[J].中西医结合肝病杂志,2010,20(3)：149-152.
3. 周利平,严伟明,陈红英,等.人纤维介素在系统性红斑狼疮和结节性血管炎患者皮损中的检测及意义[J].中国皮肤性病学杂志,2007,21(4)：210-212.
4. Marazzi S,Blum S,Hartmann R,et al.Characterization of human fibroleukin,a fibrinogen-like protein secreted by T lymphocytes[J].J Immunol.1998,161(1):138-147.
5. Ghanekar A,Mendicino M,Liu H,et al.Endothelial induction of fg12 contributes to thrombosis during acute vascular xenograft rejection[J].J Immunol.2004,172(9):5693-701
6. Gary A. Levy, mingfeng Liu, et al.Molecular and Functional Analysis of the Human Prothrombinase Gene (hFgl2) and Its Role in Viral Hepatitis[J].American Journal of Pathology.2000,156:1217-1225.
7. 陈永乐,周利平,陈红英,等.纤维介素在硬皮病血管病变中的表达[J].华中医学杂志,2006,30(5)：406-407.
8. 汪艳,王朝晖,李晓卫,等.Fg12凝血酶原酶介导的微血栓形成在2型糖尿病大鼠肾脏损害中的作用[J].微循环学杂志,2008,18(3)：12-15.
9. Ding Y, Liu K, Wang Y.Expression and significance of fgl2 prothrombinase in cardiac microvascular endothelial cells of rats with type 2 diabetes[J]. J Huazhong Univ Sci Technolog Med Sci. 2010,30(5):575-81.
10 Paul S, Tabassum S, Islam MN.Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection[J].200 4,30(2):71-77.
11. Ning Q, Sun Y, Han M, et al. Role of fibrinogen-like protein 2 prothrombinase fibroleukin in experimental and human allograft rejection[J]. J Immunol,2005,174(11):7403-7411.
12 严小枫,宁琴,严伟明,等.人纤维介素在系统性红斑狼疮患者外周血单个核细胞中的表达及意义[J].中华血液学杂志,2005,26(3)186-187.
13 余秋实,王朝晖.Fg12和TNF-α在急性心肌梗死患者和缺血再灌注大鼠外周血中表达和意义. [硕士学位论文],华中科技大学,2010.
14. Zhu F, Ning Q, Chen Y.Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity[J].Zhonghua Gan Zang Bing Za Zhi.2004,12(7):385-8.
15. 李学军,夏凌辉,魏文宁,等.重型肝炎患者Fgl2凝血酶原酶基因的表达[J].华中科技大学学报(医学版),2003,32(6)：613-615.
16. 陈悦,宁琴,王宝菊,等.重型乙型肝炎患者肝组织中人纤维介素基因的表达及意义[J].中华医学杂志,2003,83(6)：446-450.
17. 朱帆,宁琴,陈悦,等.重型乙型肝炎患者肝组织中人纤维介素基因的检测及其与临床转归关系的探讨[J].中华肝脏病杂志,2004,12(7)：385-388。
18 Clark DA, Chaouat G, Arck PC, et al. Cytokine-dependent abortion in CBA x DBA/2mice is mediated by the procoagulant fgl2 prothrombinase[J]. J Immunol,1998,160(2):545-549.
19 Simon CR, David KCC, Anthony JF. Disordered regulation of coagulation and platelet act ivation in xenotransplantation [J]. Xenotransplantation, 2000,7(3):166-175.
20 Liu Y, Xu S, Xiao F, Xiong Y,et al.The Fgl2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway[J].Biochem Biophys Res Commun.2010,9(8):369-374.
21 Gabrilovich DI, NagaraJ S.Myeloid-derived suppressor cells as regulators of the immune system [J].NatRev Immuno,2009,9(3):162-174.
22 王成,吴丹霄,刘建华,等.爆发性肝炎小鼠中髓系衍生抑制性细胞对NK细胞活性影响的研究[J].浙江大学学报,2010,39(4)：357-363.
23 蒋齐勇,王朝晖,刘青松,等.心脏缺血再灌注大鼠Th1/Th2细胞平衡与心脏微血管fg12表达的相关性[J].山东医药,2009,49(25)：20-22.
24 Yuwaraj S, Ding JW, Liu MF, et al.Genomic characterization, localization, and functional expression of FGL2,the human gene encoding fibroleukin: a novel human procoagulant[J]. Genomics,2001,71(3):330-338.
25 张天托, 周宇麒, 周风丽,等.TNF-a对小鼠腹腔渗出细胞抗真菌活性的影响[J].中国免疫学杂志,2003,19(5)：336-338.
26 Silva J S, Vespa G N, Cardoso M A, et al. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in miceby inducing nit ricoxide production in infected gama interferon-activated macrophages [J].Infect Immun,1995; 63(12):4862-4872.
27 Hunter C A, Subauste C S, Van Cleave V H et al. Production of gamma interferon by natura killer cells from Toxoplasma gondi-i infected SCID mice:regulation by interleukin-10, interleukin-12, and tumor necrosis factor plpha[J]. Infect Immun,1994; 62(7):2818-2832.
28 Liu Y, Xu S, Xiao F, et al.The Fgl2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway[J].Biochem Biophys Res Commun.2010,9(8):369-374.
29 Fukuda R, Ish imura N, Nguygen TX, et al. The expression of IL-2, IL-4 and interfer on-ganma (IFN-y) mRNA using liver biopsies at different plase of acute exacerbation of chronic hepatitis B[J]. Clin Exp Immunol, 1995,100(3):451-466.
30 Guanhua Su a,Kun Liu a,Yan Wang a, Fibrinogen-like protein 2 expression correlates with microthrombosis in rats with type 2 diabetic nephropathy Journal of Biomedical Research,2011,25(2):120-127
31 汪艳,王朝晖,苏冠华,等.FGL2凝血酶原酶在糖尿病大鼠心脏的表达及意义[J].中国糖尿病杂志.2009,17(8)：629-632.
32 Selzner N, Liu H, Boehnert MU. FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice. J Hepatol.2012,56(1):153-9.
33 Knackstedt MK, Zenclussen AC, Hertwig K, et al. Th1 cyt okines and the prothrombinase fgl2 in stress-triggered and inf lammatory abort ion. Am J Reprod Immunol,2003,49(4):210-220.
34 Su K, Chen F, Yan WM. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma[J]. World J Gastroenterol.2008,14(39):5980-9.
35 周林甫,康涛,孙东,等.隐球菌性脑膜炎及病毒性脑炎患者脑脊液IL-6、IL-10和TNF-α含量检测及其临床意义[J].神经损伤与功能重建,2011,6(2)：114-117.
36 陈利玉,蒋洪敏,韦超凡,等.结核性与新型隐球菌性脑膜炎脑脊液中NO, TNF-α及IL-8水平[J].湖南医科大学报,1997,22(6)：514-516
37 徐赤宇,温海,陈江汉.新生隐球菌感染与细胞因子的相互关系[J].国外医学(微生物学分册),2005,28(4)：30-32.
38 Kubes P, Suzuki M, Granger DN. Nitricoxide:an endogenous modulator of leukocyte adhesion[J]. Proc Natl Acd Sci USA,1991, 88(11):4651-4655
39 马德选,徐如祥.颅脑损伤时脑血管内皮细胞的表达与微循环障碍[J].中国微循环,2001,5(3)：244-246.
40 Yilmaz-Demirdag Y,Wilson B,Lowery-Nordberg M,Bocchini JA Jr,Bahna SL Interleukin-2 treatment for persistent cryptococcal meningitis in a child with idiopathic CD4(+)T lymphocytopenia [J].Allergy Asthma Proc.2008,29(4):421-425.
41 Zhang tiantuo, Kazuyoshi Kawakami, Mahboob H Qureshi,et al. Combined therapy of interleukin-12 and interleukin-18 against Cryptococcus neoformans infection in a murine model [J]. Chinese Medical Journal,2003,116(5):669-672.
42 Mucci A,L Varesio,R Neglia,et al.Antifungal activity of macrophages engineered to produce IFNgamma:inducibility by picolinic acid [J].Med Microbiol Immunol(Berlin) 2003,192:71-78.
43 Donatella Pietrella, Cristina Corbucc, Stefano Perito, et al.Mannoproteins from Cryptococcus neoformans Promote Dendritic Cell Maturation and Activation.Infection and Immunity,2005,15(3):820-827
44 原彤彤,玉艳红.hFgl2凝血酶原酶蛋白的表达与慢性重型肝炎、慢性乙型肝炎及肝癌的关系.[硕士学位论文],广西医科大学,2011